Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

Sookoian, S., Pirola, C. J.·2017·Alimentary Pharmacology & Therapeutics
DOI 10.1111/apt.14112

Cited by (230)

Items 201–230 of 230

  1. Las alteraciones de la microbiota intestinal en la patogenia del hígado graso no alcohólico
    Dannette V. Guiñez, Jaime Poniachik T., Martín Gotteland, Fabien Magne, Alvaro M. Urzua, Alexis Iracheta M., Edith Pérez de Arce, Ana María Madrid S, Luis Araya C, Daniela Vera P. et al. · 2018 · Revista Hospital Clínico Universidad de Chile
  2. [Risk factors for metabolic dysfunction-associated fatty liver disease in the Hispanic-Mexican population.]
    Jaime Morales‐Romero, María Cristina Ortiz León, Héctor Hernández-Gutierrez, Roberto A. Bahena-Cerón, Aidé Miranda-Reza, José A. Marin-Carmona, Edit Rodríguez-Romero, Silvia I Mora, Jonathan García-Román, Julio Isael Pérez‐Carreón et al. · 2023 · PubMed Central
  3. Risk Factor Evaluation of Non Alcoholic Fatty Liver Disease in Lean Individual
    Mostafa Noor Mohsin, Salahuddin Mohammed Ali Haider, Farhana Akter, Ershad Uddin Ahmed, Binoy Paul · 2022 · Journal of Chittagong Medical College Teachers Association
  4. Practical Clinical Cases in Nonalcoholic Fatty Liver Disease
    Ermina Stratina, Adrian Rotaru, Remus Stafie, Horia Octav Minea · 2023 · Springer eBooks
  5. The Effect of Sira Vedha (Phlebotomy) at Right Elbow Joint in the Management of Non-alcoholic Fatty Liver Disease - Randomized Controlled Clinical Trial
    Gaurav Rajendra Sawarkar, Priti Desai, Punam Gaurav Sawarkar · 2023 · Journal of Natural Remedies
  6. Plasma Osteopontin Level and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    2023 · The Egyptian Journal of Hospital Medicine
  7. Is Increased Caloric Intake a Feature of NAFLD Regardless of the Presence of Obesity
    Andrew Szilagyi · 2023 · Clinical Gastroenterology and Hepatology
  8. Effects of Metabolism-Related Indicators on Nonalcoholic Fatty Liver Disease in Nonobese Population Based on the National Health and Nutrition Examination Survey
    XingWang Zhu, Haiping Wang, HongLong Zhang, Guole Nie, Jun Yan, Xun� Li · 2024 · International Journal of Clinical Practice
  9. Adherence to the Mediterranean Diet: Microbiota and Non-Communicable Diseases
    Sofi G. Julien, Mireille Serhan · 2024 · Frontiers research topics
  10. Lean NAFLD: Prevalence, risk factors/pathogenesis, natural history, and treatment
    Takanori Ito, Hirokazu Takahashi · 2024 · Elsevier eBooks
  11. Chronische Erkrankungen – eine Versorgungsherausforderung
    Susanne Eble · 2024 · Springer Reference Pflege, Therapie, Gesundheit
  12. Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors
    Hikmat Pramukti, Evy Yunihastuti, Rino Alvani Gani, Ikhwan Rinaldi, Irsan Hasan, Suzy Maria · 2024 · SAGE Open Medicine
  13. Effects of Lifestyle Interventions on Metabolic Dysfunction-Associated Steatotic Liver Disease
    Anu Rani Sharma, Diana Barb · 2025 · Springer eBooks
  14. A Gastroenterologist’s Approach to Improving Metabolic Health in MASLD
    Iyiad Alabdul Razzak, Imad Alabdul Razzak, Mazen Noureddin, Hirsh D. Trivedi · 2025 · Journal of Clinical Gastroenterology
  15. Non-alcoholic steatohepatitis
    Miguel M. Pinheiro, Marta B. Afonso, Cecília M. P. Rodrigues · 2025 · Elsevier eBooks
  16. Foie métabolique
    Antonio Saviano, Lawrence Serfaty · 2025 · EMC - Hépatologie
  17. Clinical Utility of C-Reactive Protein-Triglyceride Glucose Index (CTI) and hs-CRP for Distinguishing Obese and Non-Obese Phenotypes of NAFLD: NHANES 2017-2020
    Hao Li, Chuanxin Zou · 2025 · Journal of Biosciences and Medicines
  18. Additional file 1 of Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
    Congxiang Shao, Xu, Lishu, Lei, Pingguang, Wang, Wei, Feng, Shiting, Junzhao Ye, Bihui Zhong · 2023 · Figshare
  19. Additional file 1 of Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Roderburg, Christoph, Krieg, Sarah, Krieg, Andreas, Demir, Münevver, Luedde, Tom, Kostev, Karel, Loosen, Sven H. · 2023 · Figshare
  20. Additional file 2 of Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol
    Wang, Xiaoyu, Han, Yong, Liu, Yufei, Hu, Haofei · 2022 · Figshare
  21. Additional file 1 of Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
    Chung, Goh Eun, Yu, Su Jong, Yoo, Jeong-Ju, Yuri Cho, Kyuna Lee, Dong Wook Shin, Donghee Kim, Kim, Yoon Jun, Yoon, Jung-Hwan, Han, Kyungdo et al. · 2023 · Figshare
  22. Additional file 1 of Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol
    Wang, Xiaoyu, Han, Yong, Liu, Yufei, Hu, Haofei · 2022 · Figshare
  23. Additional file 1 of Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults
    Shuying Li, Feng, Li, Ding, Jie, Weihong Zhou, Tangbin Yuan, Mao, Jiangfeng · 2023 · Figshare
  24. Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment
    Ina Bergheim, Jean François David Cadranel, Jianguo Chen, Wen‐Xing Ding, Robert Eferl, Carmen García‐Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann et al. · 2026 · Exploration of Digestive Diseases
  25. Special Population
    Janus P Ong, Hasmik Ghazinyan, Vincent Wai‐Sun Wong, Yuichiro Eguchi · 2026 · Clinics in Liver Disease
  26. Rethinking noninvasive steatosis indices: Structural limitations and misclassification across the body mass index spectrum
    Kengo Moriyama · 2026 · World Journal of Hepatology
  27. Determinants of Metabolic Dysfunction-Associated Steatotic Liver Diseases in Patients with Type 2 Diabetes Mellitus
    Monica Potra, Simona Popescu, Bogdan Timar, Sandra Lazăr, Laura Gaiţă, Adina Braha, Teodora Sorescu, Laura Diaconu, Liana Iordan, Andreea Papoi et al. · 2026 · Journal of Clinical Medicine
  28. Cancer Risk Among Young Adults With Clinically Diagnosed Fatty Liver Disease: A Nationwide Cohort Study in South Korea
    Sun Ju Lee, Yongho Jee, Ho Soo Chun, Hyun‐Young Shin · 2026 · Cancer Medicine
  29. Preventive effects of Phyllanthus emblica extract across tested doses in high-fat diet-induced obese rats
    Xiangjun Chen, Da Pan, Lanlan Gui, Ruipeng Wu, Zhengyang Hao, Ligang Yang, Shaokang Wang, Guiju Sun · 2026 · Oriental Pharmacy and Experimental Medicine
  30. Lactobacillus rhamnosus Lysate for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial
    Maryana Savytska, YI Ilkiv, Olena Baka, Еліна Манжалій, Viktoriia Yerokhovych, Dmytro Kyriienko, Tetyana Falalyeyeva, Pavlo Petakh, Iryna Halabitska, Oleksandr Kamyshnyi et al. · 2026 · Medicina